In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis
Aristides D. Tagalakis(Edge Hill University), Cynthia Yu‐Wai‐Man(King's College London), Shivam Madaan(The London College), Scott D. Larsen(University of Michigan), Saurabh Goyal(Queen Mary's Hospital Sidcup), Ian Rodrigues(St Thomas' Hospital), Peng T. Khaw(Moorfields Eye Hospital NHS Foundation Trust), Kin Sheng Lim(Cheil General Hospital and Women's Healthcare Center), Richard R. Neubig(Grand Rapids Community College)
Cited by 40
Related Papers
Genome-wide analyses identify 68 new loci associated with intraocular pressure and improve risk prediction for primary open-angle glaucoma
|Nature Genetics|2018|384
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up
|Ophthalmology|2018|320
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up
|Ophthalmology|2019|252